| Identification | Back Directory | [Name]
Androst-5-en-3-ol, 16,17-epoxy-17-(3-pyridinyl)-, 3-acetate, (3β,16α,17α)- | [CAS]
2484719-11-9 | [Synonyms]
Abiraterone impurities428
Androst-5-en-3-ol, 16,17-epoxy-17-(3-pyridinyl)-, 3-acetate, (3β,16α,17α)-
Androst-5-en-3-ol, 16,17-epoxy-17-(3-pyridinyl)-, 3-acetate, (3β,16α,17α)-
Alpha-Epoxyabiraterone acetateQ: What is
Alpha-Epoxyabiraterone acetate Q: What is the CAS Number of
Alpha-Epoxyabiraterone acetate
(4S,6aR,6bS,8aS,8bR,9aR,10aS,10bR)-6a,8a-dimethyl-8b-(pyridin-3-yl)-3,4,5,6,6a,6b,7,8,8a,8b,9a,10,10a,10b-tetradecahydro-1H-naphtho[2',1':4,5]indeno[1,2-b]oxiren-4-yl acetate | [Molecular Formula]
C26H33NO3 | [MOL File]
2484719-11-9.mol | [Molecular Weight]
407.55 |
| Chemical Properties | Back Directory | [Boiling point ]
521.0±50.0 °C(Predicted) | [density ]
1.20±0.1 g/cm3(Predicted) | [solubility ]
Chloroform (Slightly), Ethanol (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
5.39±0.12(Predicted) | [color ]
White to Pale Beige | [Stability:]
Hygroscopic |
| Hazard Information | Back Directory | [Uses]
α-Epoxyabiraterone Acetate is an impurity of Abiraterone (A108490), a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer. |
|
|